skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,036  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: resource type: Conference Proceedings remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
111 Evaluation of survival outcomes from delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer
111 Evaluation of survival outcomes from delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Material Type:
Conference Proceeding 		Add to My Research

111 Evaluation of survival outcomes from delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer

International journal of gynecological cancer, 2020, Vol.30 (Suppl 4), p.A56-A56 [Peer Reviewed Journal]

2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-ESGO.101

Full text available

Citations Cited by
2
052: BARRIERS TO HEALTH RESEARCH USE IN KENYA AND MALAWI
052: BARRIERS TO HEALTH RESEARCH USE IN KENYA AND MALAWI
Material Type:
Conference Proceeding 		Add to My Research

052: BARRIERS TO HEALTH RESEARCH USE IN KENYA AND MALAWI

BMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.52 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.52

Full text available

Citations Cited by
3
O33 Qualitative story completion: an innovative method with exciting potential for health research
O33 Qualitative story completion: an innovative method with exciting potential for health research
Material Type:
Conference Proceeding 		Add to My Research

O33 Qualitative story completion: an innovative method with exciting potential for health research

BMJ open, 2019, Vol.9 (Suppl 1), p.A13-A13 [Peer Reviewed Journal]

2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.33

Full text available

Citations Cited by
4
1272 Probabilistic mixture models improve calibration of panel-derived tumor mutational burden in the context of both tumor-normal and tumor-only sequencing
1272 Probabilistic mixture models improve calibration of panel-derived tumor mutational burden in the context of both tumor-normal and tumor-only sequencing
Material Type:
Conference Proceeding 		Add to My Research

1272 Probabilistic mixture models improve calibration of panel-derived tumor mutational burden in the context of both tumor-normal and tumor-only sequencing

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1320-A1321 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1272

Full text available

Citations Cited by
5
750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies
750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies
Material Type:
Conference Proceeding 		Add to My Research

750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A783-A783 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0750

Full text available

Citations Cited by
6
364 Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/ENGOT-OV26/GOG-3012 study
364 Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/ENGOT-OV26/GOG-3012 study
Material Type:
Conference Proceeding 		Add to My Research

364 Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/ENGOT-OV26/GOG-3012 study

International journal of gynecological cancer, 2020, Vol.30 (Suppl 4), p.A70-A71 [Peer Reviewed Journal]

2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-ESGO.124

Full text available

Citations Cited by
7
Optimize Wav2vec2s Architecture for Small Training Set Through Analyzing its Pre-Trained Models Attention Pattern
Optimize Wav2vec2s Architecture for Small Training Set Through Analyzing its Pre-Trained Models Attention Pattern
Material Type:
Conference Proceeding 		Add to My Research

Optimize Wav2vec2s Architecture for Small Training Set Through Analyzing its Pre-Trained Models Attention Pattern

The Institute of Electrical and Electronics Engineers, Inc. (IEEE) Conference Proceedings, 2022

Copyright The Institute of Electrical and Electronics Engineers, Inc. (IEEE) 2022 ;DOI: 10.1109/ICASSP43922.2022.9747831

Digital Resources/Online E-Resources

Citations Cited by
8
Increasing the User Experience Research Maturity of a Global Accommodation Comparison Platform
Increasing the User Experience Research Maturity of a Global Accommodation Comparison Platform
Material Type:
Conference Proceeding 		Add to My Research

Increasing the User Experience Research Maturity of a Global Accommodation Comparison Platform

International Conference on Tourism Research, 2023, Vol.6 (1), p.233-240 [Peer Reviewed Journal]

Copyright Academic Conferences International Limited Jun 2023 ;ISSN: 2516-3604 ;ISSN: 2516-3612 ;EISSN: 2516-3612 ;DOI: 10.34190/ictr.6.1.1230

Full text available

Citations Cited by
9
P17 Adopting the nominal group technique to understand the use of religious practices and experiences
P17 Adopting the nominal group technique to understand the use of religious practices and experiences
Material Type:
Conference Proceeding 		Add to My Research

P17 Adopting the nominal group technique to understand the use of religious practices and experiences

BMJ open, 2019, Vol.9 (Suppl 1), p.A20-A20 [Peer Reviewed Journal]

2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.52

Full text available

Citations Cited by
10
769 Results from an ongoing open-label, multicenter, phase 1 trial of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors
769 Results from an ongoing open-label, multicenter, phase 1 trial of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors
Material Type:
Conference Proceeding 		Add to My Research

769 Results from an ongoing open-label, multicenter, phase 1 trial of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A800-A800 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0769

Full text available

Citations Cited by
11
1135 Single cell resolution of immune responses to oncolytic herpes simplex virus C134 in preclinical medulloblastoma models
1135 Single cell resolution of immune responses to oncolytic herpes simplex virus C134 in preclinical medulloblastoma models
Material Type:
Conference Proceeding 		Add to My Research

1135 Single cell resolution of immune responses to oncolytic herpes simplex virus C134 in preclinical medulloblastoma models

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1179-A1179 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1135

Full text available

Citations Cited by
12
1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates
1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates
Material Type:
Conference Proceeding 		Add to My Research

1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1198-A1198 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1155

Full text available

Citations Cited by
13
715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials
715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials
Material Type:
Conference Proceeding 		Add to My Research

715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A748-A748 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0715

Full text available

Citations Cited by
14
526 miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
526 miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
Material Type:
Conference Proceeding 		Add to My Research

526 miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A551-A551 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0526

Full text available

Citations Cited by
15
021: SEROPREVALENCE OF HISTOPLASMA CAPSULATUM INFECTION AMONG THE NEARBY RESIDENTS OF BAT CAVES IN ISLAND GARDEN CITY OF SAMAL, DAVAO DEL NORTE
021: SEROPREVALENCE OF HISTOPLASMA CAPSULATUM INFECTION AMONG THE NEARBY RESIDENTS OF BAT CAVES IN ISLAND GARDEN CITY OF SAMAL, DAVAO DEL NORTE
Material Type:
Conference Proceeding 		Add to My Research

021: SEROPREVALENCE OF HISTOPLASMA CAPSULATUM INFECTION AMONG THE NEARBY RESIDENTS OF BAT CAVES IN ISLAND GARDEN CITY OF SAMAL, DAVAO DEL NORTE

BMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.21 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.21

Full text available

Citations Cited by
16
058: EVALUATING A COMPLEX CAPACITY-BUILDING INTERVENTION IN AN INTERNATIONAL DEVELOPMENT CONTEXT: REFLECTING ON THE AFRICAN INSTITUTIONS INITIATIVE EVALUATION
058: EVALUATING A COMPLEX CAPACITY-BUILDING INTERVENTION IN AN INTERNATIONAL DEVELOPMENT CONTEXT: REFLECTING ON THE AFRICAN INSTITUTIONS INITIATIVE EVALUATION
Material Type:
Conference Proceeding 		Add to My Research

058: EVALUATING A COMPLEX CAPACITY-BUILDING INTERVENTION IN AN INTERNATIONAL DEVELOPMENT CONTEXT: REFLECTING ON THE AFRICAN INSTITUTIONS INITIATIVE EVALUATION

BMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.58 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.58

Full text available

Citations Cited by
17
Assessment of Medical Geology from Major Element Trilinear Diagrams Cl-SO4-HCO3 and Na-K-Mg from Geothermal and Non-Geothermal Springs; Case Study the Wayang Windu Geothermal Area, West Java, Indonesia
Assessment of Medical Geology from Major Element Trilinear Diagrams Cl-SO4-HCO3 and Na-K-Mg from Geothermal and Non-Geothermal Springs; Case Study the Wayang Windu Geothermal Area, West Java, Indonesia
Material Type:
Conference Proceeding 		Add to My Research

Assessment of Medical Geology from Major Element Trilinear Diagrams Cl-SO4-HCO3 and Na-K-Mg from Geothermal and Non-Geothermal Springs; Case Study the Wayang Windu Geothermal Area, West Java, Indonesia

IOP conference series. Earth and environmental science, 2024, Vol.1293 (1), p.012002 [Peer Reviewed Journal]

Published under licence by IOP Publishing Ltd. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1755-1307 ;EISSN: 1755-1315 ;DOI: 10.1088/1755-1315/1293/1/012002

Full text available

Citations Cited by
18
Pharmacokinetic Modeling of VV116 for Treatment of COVID-19
Pharmacokinetic Modeling of VV116 for Treatment of COVID-19
Material Type:
Conference Proceeding 		Add to My Research

Pharmacokinetic Modeling of VV116 for Treatment of COVID-19

BIO Web of Conferences, 2023, Vol.60, p.2007 [Peer Reviewed Journal]

2023. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2117-4458 ;ISSN: 2273-1709 ;EISSN: 2117-4458 ;DOI: 10.1051/bioconf/20236002007

Full text available

Citations Cited by
19
Optimizing Point Cloud Processing for Facial Reconstruction Using Open-Source Tools: A Preliminary Study
Optimizing Point Cloud Processing for Facial Reconstruction Using Open-Source Tools: A Preliminary Study
Material Type:
Conference Proceeding 		Add to My Research

Optimizing Point Cloud Processing for Facial Reconstruction Using Open-Source Tools: A Preliminary Study

Central European Conference on Information and Intelligent Systems, 2023, p.361-368

2023. This work is published under http://archive.ceciis.foi.hr/app/index.php/ceciis/archive (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1847-2001 ;EISSN: 1848-2295

Full text available

Citations Cited by
20
Towards Computational Content Analysis of Crises-Related News in Electronic Media
Towards Computational Content Analysis of Crises-Related News in Electronic Media
Material Type:
Conference Proceeding 		Add to My Research

Towards Computational Content Analysis of Crises-Related News in Electronic Media

Central European Conference on Information and Intelligent Systems, 2023, p.407-416

2023. This work is published under http://archive.ceciis.foi.hr/app/index.php/ceciis/archive (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1847-2001 ;EISSN: 1848-2295

Full text available

Citations Cited by

Results 1 - 20 of 3,036  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1983  (15)
  2. 1983 To 1997  (14)
  3. 1998 To 2005  (86)
  4. 2006 To 2014  (601)
  5. After 2014  (2,326)
  6. More options open sub menu

Language 

  1. English  (3,007)
  2. German  (12)
  3. French  (7)
  4. Hungarian  (4)
  5. Spanish  (3)
  6. Japanese  (3)
  7. Russian  (2)
  8. Polish  (1)
  9. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait